Publication | Closed Access

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

Non-hodgkin LymphomasLymphoid NeoplasiaHematological MalignancyTransplantationConcurrent MycMedicineImmunologyHematologyCell TransplantationBcl2 RearrangementsImmunotherapyOncologyRadiation OncologyHealth Sciences